Efficacy of Small Bowel Preparation in Capsule Endoscopy (PREPINTEST)

June 6, 2016 updated by: University Hospital, Brest

Impact of Small Bowel Preparation Using Polyethylene Glycol for Endoscopic Video-capsule (EVC)Exploration in Unexplained Gastrointestinal Bleedings

The best preparation of small bowel is still unknown. The primary aim of this study is to evaluate the polyethylene glycol (PEG) impact of small bowel preparation for unexplained gastrointestinal bleeding exploration. Three different preparations are evaluated in this study.

Study Overview

Detailed Description

Now days, the endoscopic video-capsule is the more appropriate exam for unexplained gastrointestinal bleeding exploration. The responsible damage of this unexplained bleeding are frequently small vascular damages, hard to be detected in the bowel or ulcerations or tumors. The exam quality can be limited by food residues, bubbles or bile.

30% of damage are probably undetectable because of a lack of visibility. An efficient preparation will probably increased the quality of the video-capsule exploration.

The bowel exploration by endoscopy video-capsule will be realized in the usual condition. The study included 4 steps:

  1. Inclusion
  2. Randomization
  3. Video-capsule exploration
  4. Reading of the video-capsule exam by endoscopist doctors who are in blind.

Study Type

Interventional

Enrollment (Actual)

858

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Avignon, France, 84000
        • Centre Hospitalier d'Avignon
      • Beziers, France
        • Cabinet privé
      • Bobigny, France, 93000
        • Centre Hospitalier d'Avicenne
      • Brest, France, 29200
        • CHOLET
      • Lille, France, 59037
        • CHRU de Lille
      • Lomme, France, 59160
        • Saint Philibert Hospital
      • Lorient, France, 56100
        • CH Bretagne Sud
      • Lyon, France, 69437
        • Edouard Herriot Hospital
      • Marseille, France, 13385
        • Hopital de la Timone
      • Marseille, France, 13274
        • Hôpital de la Conception
      • Nice, France, 06202
        • Centre Hospitalier Universitaire de Nice
      • Paris, France, 75014
        • Hôpital Cochin
      • Paris, France, 75015
        • Höpital Européen Geores Pompidou
      • Quimper, France, 29000
        • CH de Cornouaille Quimper
      • Saint Brieuc, France, 22000
        • Centre Hospitalier de Saint Brieuc
      • Saint Priest, France, 69800
        • Hôpital Privé de L'Est Lyonnais
      • Vannes, France, 56017
        • CH Bretagne Atlantique

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age >= 18 years old.
  • Patients who have an indication for video-capsule endoscopy exploration for unexplained gastrointestinal bleeding associated with anaemia (man : haemoglobin <13 g/dl and woman haemoglobin <12g/dl)
  • Less than one year Endoscopic assessment by colonoscopy and gastroscopy
  • Not participated to an another clinic study.
  • Written consent.

Exclusion Criteria:

  • Age<18 years old.
  • General physical health deterioration such as dehydration or cardiac insufficiency.
  • Clinical or radiological suspicion of digestive stenosis.
  • Oral iron taking in the 4 days before video-capsule exploration.
  • Functional or organic disorders of the gulp
  • Pregnant women.
  • Sensibility known about the polyethylene glycol.
  • No signed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Preparation 1
Standard diet: the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

After the lunch the day before the exploration, drink only clear liquids and stop solid food.

From 10 pm, stay fasting, don't drink except the usual drugs taken with mouthful of water until the exploration by video-capsule endoscopy.

Active Comparator: Preparation 2

Standard diet : the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

500 ml of polyethylene glycol 30 minutes after the ingestion of video-capsule endoscopy.

Apply the standard diet and drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.
Active Comparator: Preparation 3

Standard diet : the day before video-capsule exploration : Drink only clears liquids after the lunch, fasting from 22 hours except usual drugs with a mouthful water.

2 liters of polyethylene glycol between 7 pm and 9 pm.

500 ml of polyethylene glycol, 30 minutes after the ingestion of video-capsule endoscopy.

apply the standard diet and drink 2 liters of polyethylene glycol between 19h and 21h the day before exploration. Then drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare the frequencies of the diagnoses of clinically significant lesions
Time Frame: at the end of video-capsule exploration
Compare the frequencies of the diagnoses of clinically significant lesions (P1 or P2)obtained with and without polyethylene glycol preparation for patients investigated by video-capsule endoscopy who have an unexplained digestive bleeding.
at the end of video-capsule exploration

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The quality of the preparation and visibility of the bowel
Time Frame: at the end of video-capsule exploration
Demonstrate an improvement in preparation quality and bowel visibility in the various segments of small bowel examined by video-capsule endoscopy
at the end of video-capsule exploration
The clinical tolerance
Time Frame: 8 days after video-capsule exploration
Evaluate the clinical tolerance and the acceptability of the bowel preparation with oral polyethylene glycol solution
8 days after video-capsule exploration
The number of all the observed lesions
Time Frame: at the end of video-capsule exploration
Estimate the number of all the observed lesions on the recording according to their hemorrhagic potential.
at the end of video-capsule exploration
Compare different times
Time Frame: at the end of video-capsule exploration
Compare gastric emptying time, the bowel transit time and the percentage complete medical exploration of small bowel for every group of patients (ileo- cecal valve exceeded).
at the end of video-capsule exploration
Crossing (yes or no) of ileo-cecal valve by the EVC
Time Frame: At the end of video-capsule exploration
At the end of video-capsule exploration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Franck CHOLET, MD, CHRU Brest

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

December 27, 2010

First Submitted That Met QC Criteria

December 28, 2010

First Posted (Estimate)

December 29, 2010

Study Record Updates

Last Update Posted (Estimate)

June 7, 2016

Last Update Submitted That Met QC Criteria

June 6, 2016

Last Verified

June 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Bleedings

Clinical Trials on Standard diet

3
Subscribe